ES2171008T3 - Preparacion de amilosa reticulada util como un excipiente para liberacion controlada de compuestos activos. - Google Patents

Preparacion de amilosa reticulada util como un excipiente para liberacion controlada de compuestos activos.

Info

Publication number
ES2171008T3
ES2171008T3 ES98902905T ES98902905T ES2171008T3 ES 2171008 T3 ES2171008 T3 ES 2171008T3 ES 98902905 T ES98902905 T ES 98902905T ES 98902905 T ES98902905 T ES 98902905T ES 2171008 T3 ES2171008 T3 ES 2171008T3
Authority
ES
Spain
Prior art keywords
cross
linked
high amylose
amylose starch
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES98902905T
Other languages
English (en)
Inventor
Yves Dumoulin
Francois Carriere
Andre Ingenito
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Labopharm Inc
Original Assignee
Labopharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Labopharm Inc filed Critical Labopharm Inc
Application granted granted Critical
Publication of ES2171008T3 publication Critical patent/ES2171008T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B31/00—Preparation of derivatives of starch
    • C08B31/003—Crosslinking of starch
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B33/00—Preparation of derivatives of amylose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Saccharide Compounds (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A UN PROCEDIMIENTO PARA LA PRODUCCION INDUSTRIAL EN UN MEDIO ACUOSO DE UN EXCIPIENTE DE LIBERACION LENTA QUE CONSISTE BASICAMENTE EN LA AMILOSIS RETICULADA QUE TIENE PROPIEDADES DE LIBERACION CONTROLADA, PARA SU USO EN LA PREPARACION DE COMPRIMIDOS O DE GRANULADOS. SE SOMETE PRIMERO UN ALMIDON QUE CONTIENE UNA CANTIDAD ELEVADA DE AMILOSIS (ALMIDON CON ALTO CONTENIDO DE AMILOSIS) A UNA GELIFICACION. SE SOMETE LUEGO ESTE ALMIDON GELIFICADO A UNA RETICULACION MEDIANTE 1 A 5 GR DE AGENTE DE RETICULACION PARA 100 GR DE ALMIDON GELIFICADO DE BASE SECA EN UN MEDIO ALCALINO, LO QUE PERMITE OBTENER UN MEDIO REACCIONAL QUE CONTIENE UN PRODUCTO REACCIONAL QUE CONSISTE EN UNA PASTA LIQUIDA DE ALMIDON RETICULADO DE ALTO CONTENIDO DE AMILOSIS. SE NEUTRALIZA EL MEDIO REACCIONAL OBTENIDO, Y ELLO PERMITE LA OBTENCION DE PRODUCTOS SECUNDARIOS CONSTITUIDOS BASICAMENTE POR SALES, QUE SE QUITAN DEL MEDIO REACCIONAL. SE SOMETE LUEGO LA PASTA LIQUIDA DE ALMIDON RETICULADO RECUPERADA A UN TRATAMIENTO TERMICO A UNA TEMPERATURA DE, POR LO MENOS, 60 GRADOS C Y SE SECA EL PRODUCTO TRATADO TERMICAMENTE PARA OBTENER EL EXCIPIENTE DESEADO CON LIBERACION LENTA. ESTE PROCESO ES ECONOMICO Y TIENE VENTAJAS DESDE EL PUNTO DE VISTA INDUSTRIAL, PUESTO QUE SE EJECUTA EN UN MEDIO ACUOSO.
ES98902905T 1997-02-14 1998-02-10 Preparacion de amilosa reticulada util como un excipiente para liberacion controlada de compuestos activos. Expired - Lifetime ES2171008T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/800,518 US5807575A (en) 1997-02-14 1997-02-14 Manufacture of cross-linked amylose useful as a excipient for control release of active compounds

Publications (1)

Publication Number Publication Date
ES2171008T3 true ES2171008T3 (es) 2002-08-16

Family

ID=25178603

Family Applications (1)

Application Number Title Priority Date Filing Date
ES98902905T Expired - Lifetime ES2171008T3 (es) 1997-02-14 1998-02-10 Preparacion de amilosa reticulada util como un excipiente para liberacion controlada de compuestos activos.

Country Status (12)

Country Link
US (1) US5807575A (es)
EP (1) EP0960131B1 (es)
AT (1) ATE212040T1 (es)
AU (1) AU726272B2 (es)
CA (1) CA2280534C (es)
DE (1) DE69803159T2 (es)
DK (1) DK0960131T3 (es)
ES (1) ES2171008T3 (es)
IL (1) IL131369A (es)
NZ (1) NZ337171A (es)
PT (1) PT960131E (es)
WO (1) WO1998035992A1 (es)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7153845B2 (en) * 1998-08-25 2006-12-26 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets
US6248358B1 (en) 1998-08-25 2001-06-19 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets and methods of making and using the same
US6624200B2 (en) 1998-08-25 2003-09-23 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets
US8765177B2 (en) * 1997-09-12 2014-07-01 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets
US6284273B1 (en) * 1998-02-24 2001-09-04 Vincent Lenaerts Cross-linked high amylose starch resistant to amylase as a matrix for the slow release of biologically active compounds
GB9924351D0 (en) 1999-10-14 1999-12-15 Brennan Frank Immunomodulation methods and compositions
US6607748B1 (en) * 2000-06-29 2003-08-19 Vincent Lenaerts Cross-linked high amylose starch for use in controlled-release pharmaceutical formulations and processes for its manufacture
EP1347748A2 (en) 2000-12-05 2003-10-01 MacGregor, Alexander Hydrostatic delivery system for controlled delivery of agent
CA2423712A1 (en) 2003-03-26 2004-09-26 Nicolas Nourry Crosslinked amylopectin by reactive extrusion and its use as an absorbent or superabsorbent material
US8487002B2 (en) * 2002-10-25 2013-07-16 Paladin Labs Inc. Controlled-release compositions
TWI319713B (en) * 2002-10-25 2010-01-21 Sustained-release tramadol formulations with 24-hour efficacy
EP1565167B1 (en) * 2002-11-07 2016-06-22 Advanced Bionutrition Corporation Nutraceuticals and method of feeding aquatic animals
US6846497B2 (en) * 2003-01-30 2005-01-25 National Starch And Chemical Investment Holding Corporation Rapidly expanding starches with altered crystalline structure
US20060172006A1 (en) * 2003-10-10 2006-08-03 Vincent Lenaerts Sustained-release tramadol formulations with 24-hour clinical efficacy
US8309077B2 (en) 2004-11-02 2012-11-13 Chr. Hansen A/S Stabilized bacteriophage formulations
CA2491665A1 (fr) * 2004-12-24 2006-06-24 Louis Cartilier Formulation de comprime pour liberation soutenue de principe actif
EA014739B1 (ru) * 2005-09-09 2011-02-28 Лабофарм Инк. Композиция тразодона для введения один раз в день
RU2008113439A (ru) 2005-09-09 2009-10-20 Лабофарм Инк. (CA) Композиции с замедленным высвобождением лекарственного средства
US20090074829A1 (en) * 2006-03-14 2009-03-19 Masao Tanihara Novel Heparin Alternative Material and Method for Producing the Same
JP5453280B2 (ja) * 2007-10-16 2014-03-26 ラボファーム インコーポレイテッド アセトアミノフェンおよびトラマドールを持続的に放出するための二層組成物
US8563066B2 (en) * 2007-12-17 2013-10-22 New World Pharmaceuticals, Llc Sustained release of nutrients in vivo
AR069960A1 (es) 2007-12-28 2010-03-03 Acraf Formulacion farmaceutica de liberacion controlada y procedimiento para su preparacion
AP2975A (en) * 2008-07-16 2014-09-30 Richter Gedeon Nyrt Pharmaceutical formulations containing dopamine receptor ligands
WO2010028489A1 (en) * 2008-09-15 2010-03-18 Labopharm Inc. Starch-based microparticles for the release of agents disposed therein
SG171444A1 (en) 2009-01-23 2011-07-28 Acraf Controlled release pharmaceutical or food formulation and process for its preparation
US11274087B2 (en) 2016-07-08 2022-03-15 Richter Gedeon Nyrt. Industrial process for the preparation of cariprazine
GB2567493B (en) 2017-10-13 2019-12-18 Altus Formulation Inc Starch-based release modifying excipients and pharmaceutical compositions derived therefrom
US11547707B2 (en) 2019-04-10 2023-01-10 Richter Gedeon Nyrt. Carbamoyl cyclohexane derivatives for treating autism spectrum disorder

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2987445A (en) * 1958-10-10 1961-06-06 Rohm & Haas Drug composition
US3087860A (en) * 1958-12-19 1963-04-30 Abbott Lab Method of prolonging release of drug from a precompressed solid carrier
US3622677A (en) * 1969-07-07 1971-11-23 Staley Mfg Co A E Compressed tablets containing compacted starch as binder-disintegrant ingredient
US4369308A (en) * 1981-07-24 1983-01-18 National Starch And Chemical Corporation Low swelling starches as tablet disintegrants
US4667590A (en) * 1984-12-10 1987-05-26 Mars, Inc. Closed food processing system and liquid adjustment apparatus for use therein
CA2041774C (en) * 1990-11-27 1994-04-19 Mircea A. Mateescu Use of cross-linked amylose as a matrix for the slow release of biologically active compounds
HU221591B (hu) * 1992-07-24 2002-11-28 Labopharm Inc. Keresztkötéses polihidroxil-származék enzimatikusan szabályozott hatóanyag-kibocsátáshoz

Also Published As

Publication number Publication date
IL131369A (en) 2002-12-01
ATE212040T1 (de) 2002-02-15
AU726272B2 (en) 2000-11-02
EP0960131B1 (en) 2002-01-16
AU5978598A (en) 1998-09-08
CA2280534C (en) 2003-08-19
CA2280534A1 (en) 1998-08-20
WO1998035992A1 (en) 1998-08-20
DK0960131T3 (da) 2002-05-06
PT960131E (pt) 2002-06-28
DE69803159T2 (de) 2002-08-29
IL131369A0 (en) 2001-01-28
US5807575A (en) 1998-09-15
EP0960131A1 (en) 1999-12-01
NZ337171A (en) 2000-09-29
DE69803159D1 (de) 2002-02-21

Similar Documents

Publication Publication Date Title
PT960131E (pt) Fabrico de amilose recticulada util como excipiente para a libertacao controlada de compostos activos
US4388288A (en) Preparation of shaped titanium dioxide catalyst/carrier and catalysis of gaseous sulfur compounds therewith
MY128308A (en) Cross-linked high amylose starch for use in controlled-release pharmaceutical formulations and processes for its manufacture
JPH0531000A (ja) 天然又は合成高分子化合物の選択的加水分解及び／又は熱分解方法
US20100311904A1 (en) Biodegradable absorbent material and method of manufacture
PL348976A1 (en) Isocyanate-based polymer foam and process for production thereof
US6010717A (en) Starch products as tabletting excipient, method for preparing same, and method for making tablets
ES2024005B3 (es) Procedimiento continuo para fabricacion de granulados de perborato de sodio
MX9706062A (es) FORMAS DE DOSIFICACION ORAL CONTENIENDO UN ANTIBIOTICO DE beta -LACTAMA.
ES2160912T3 (es) Procedimiento e instalacion para la produccion de nitrato de amoniaco poroso.
JPS5857430B2 (ja) 顆粒状ジクロロイソシアヌル酸アルカリ金属塩の製法
HU225089B1 (en) Process for preparing nicotinic acid
US4008234A (en) Process for the preparation of melon
JP2004238622A (ja) 変更された結晶構造を有する急速膨張性澱粉
EP0604112A3 (en) Process for converting chlorine end-terminated polyorganosiloxanes to polyorganocyclosiloxanes
KR20030066076A (ko) 변성전분의 제조방법
US1159364A (en) Catalyst for the production of ammonia and process of making the same.
JPS5857217B2 (ja) 油溶性物質含有の流動性顆粒状物質の製造方法
BR0211841A (pt) Secagem de artigos cerâmicos durante manufatura
US3657236A (en) Production of melamine
JPS5761610A (en) Preparation of active carbon
NO20005752D0 (no) Fremgangsmåte for fremstilling av sammensatte gjödningsmidler
JPS609010B2 (ja) 熱安定性の良いジクロロイソシアヌル酸ナトリウム錠剤の製法
SU691436A1 (ru) Способ устранени слеживаемости граннулированного удобрени
JPS6113486B2 (es)

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 960131

Country of ref document: ES